Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 16, 2025 07:00 ET | Source: AccuStem Sciences, Inc.

AccuStem Sciences, Inc. Signs Agreement to Access Blood Samples from Lung Cancer Screening Trial to Expedite MSC Commercialization Plan

LONDON and PHOENIX, April 16, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of...
March 18, 2025 08:30 ET | Source: AccuStem Sciences, Inc.

AccuStem Sciences, Inc. Announces Acquisition of Proprietary MSC Lung Cancer Screening Test

AccuStem pursuing strategic commercialization plan intending to launch the MSC test in the US in 2026 LONDON and PHOENIX, Ariz., March 18, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB:...
July 06, 2023 10:08 ET | Source: The Insight Partners

8.2% CAGR for Lung Cancer Screening Market Worth $4.36Bn by 2030 with NSCLC Segment (8% CAGR) Driving Growth During 2022-2030 | The Insight Partners

Pune, India, July 06, 2023 (GLOBE NEWSWIRE) -- According to Recently Published Report by The Insight Partners, “Lung Cancer Screening Market Size Report and Forecast to 2030 - COVID-19 Impact and...
February 04, 2019 12:25 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies Announces Award of Canadian Patent

SAN ANTONIO, Feb. 04, 2019 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, announced that the Canadian Intellectual Property Office has awarded a patent expanding the...
October 19, 2015 18:04 ET | Source: American College of Chest Physicians

Study finds 43 percent of patients undergoing lung cancer screening experience elevated levels of distress

GLENVIEW, Ill., Oct. 19, 2015 (GLOBE NEWSWIRE) -- Low-dose computed tomography (LDCT) lung cancer screening is recommended to screen patients with an increased risk of developing lung cancer, but...